Exhibit 10.14
ADVAXIS, INC
▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
PHONE: (▇▇▇) ▇▇▇-▇▇▇▇
FAX: (▇▇▇) ▇▇▇-▇▇▇▇
Thursday, June 19, 2003
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, PhD
DNA Bridges, Inc. ("DNA")
▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇.
▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇
Dear ▇▇▇▇▇▇,
RE: GRANT WRITING AGREEMENT
This letter summarizes our understanding regarding the terms and conditions of
the engagement for the purpose of DNA's implementation and execution of a grant
writing strategy for Advaxis, Inc ("Advaxis" or "Company"):
1) Project:
a) Implement and execute a grant writing strategy on behalf of Advaxis
based on the schedule and grants specified in SCHEDULE A.
Specifically:
2) Developing and managing proposal development timeline
3) Gathering relevant background material
4) Writing the grant
5) Editing grant and working with client to fine tune the grant
application
6) Preparing budget requirements for grant
7) Prepare forms prior to submission (form review by the company
must be completed one week prior to the final submission
target date)
8) All other items reasonably necessary to submit the grant
9) Payment schedule: As described in SCHEDULE B.
10) Conflict of interest: If a conflict of interest should arise during the
performance of this Agreement, DNA shall immediately notify Company
thereof.
11) Confidentiality: the terms of the existing confidentiality agreement
between DNA and Advaxis shall apply.
12) Assignment of Inventions. DNA agrees that DNA will promptly make full
written disclosure to Company, will hold in trust for the sole right and
benefit of Company, and hereby assigns, transfers and conveys to Company,
or its designee, all of DNA's worldwide right, title, and interest in and
to any and all inventions, original works of authorship, findings,
conclusions, data, discoveries, developments, concepts, improvements,
trade secrets, techniques, processes and know-how, whether or not
patentable or registrable under copyright or similar laws, which DNA may
solely or jointly conceive or develop or reduce to practice, or cause to
be conceived or developed or reduced to practice, in the performance of
the services under this agreement or which result, to any extent, from use
of Company's premises or property.
13) Independent Contractor. For purposes of this Agreement and all Services to
be provided hereunder, DNA shall not be considered a partner, co-venturer,
agent, employee or representative of Company, but shall remain in all
respects an independent contractor, and neither party shall have any right
or authority to make or undertake any promise, warranty or representation,
to execute any contract, or otherwise to assume any obligation or
responsibility in the name of or on behalf of the other party.
14) Termination: Each party may terminate this agreement with a 30 day prior
notice.
15) Amendment: This Agreement constitutes the entire agreement between the
parties with respect to the subject matter hereof. This Agreement may not
be amended, modified or waived, except in writing signed by both parties.
Both parties may agree in writing to amend this agreement or any of its
schedules.
16) Dispute resolution: Any dispute that arises in connection with agreement
shall be determined by arbitration conducted in Princeton, New Jersey, in
accordance with the Commercial Arbitration Rules of the American
Arbitration Association then existing.
IN WITNESS HEREOF, the parties have read and agree to be bound by the above
terms and conditions and have entered into this Agreement effective as of the
date set forth above.
ADVAXIS, INC DNA BRIDGES, INC
Signature: /s/ J. ▇▇▇▇ ▇▇▇▇▇▇ Signature: /s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇
------------------------- -------------------------
Name Name: ▇▇▇▇▇▇ ▇▇▇▇▇▇
Title: Title:
EIN#: ▇▇-▇▇▇▇▇▇▇
Date: Date:
------------------------- -------------------------------